Ultragenyx Pharmaceutical Inc. Quarterly Unrecognized Tax Benefits in USD from Q4 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Ultragenyx Pharmaceutical Inc. quarterly Unrecognized Tax Benefits history and growth rate from Q4 2011 to Q4 2023.
  • Ultragenyx Pharmaceutical Inc. Unrecognized Tax Benefits for the quarter ending December 31, 2023 was $80M, a 19.8% increase year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $80M +$13.2M +19.8% Dec 31, 2023 10-K 2024-02-21
Q4 2022 $66.8M +$11.4M +20.7% Dec 31, 2022 10-K 2024-02-21
Q4 2021 $55.4M +$8.7M +18.6% Dec 31, 2021 10-K 2024-02-21
Q4 2020 $46.7M +$6.71M +16.8% Dec 31, 2020 10-K 2024-02-21
Q4 2019 $40M +$6.23M +18.5% Dec 31, 2019 10-K 2023-02-17
Q4 2018 $33.7M +$5.35M +18.9% Dec 31, 2018 10-K 2022-02-15
Q4 2017 $28.4M +$14.9M +110% Dec 31, 2017 10-K 2021-02-12
Q4 2016 $13.5M -$10.5M -43.8% Dec 31, 2016 10-K 2020-02-14
Q4 2015 $24M +$16.7M +230% Dec 31, 2015 10-K 2019-02-20
Q4 2014 $7.28M +$3.55M +95.3% Dec 31, 2014 10-K 2018-02-21
Q4 2013 $3.73M +$2.17M +140% Dec 31, 2013 10-K 2017-02-17
Q4 2012 $1.55M +$1.23M +379% Dec 31, 2012 10-K 2016-02-26
Q4 2011 $324K Dec 31, 2011 10-K 2015-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.